Intellectual Property Office Home University of Cincinnati
News
Technologies
Issued US Patents
UC Technology Startups
Forms
Our Mission
IP Overview
Patents
Copyright
Licensing
Conflicts
Policies and Law
Annual Reports
Staff and Location
Contact Us
Links
UC Directory
IPO Home

Case Number 100037 - Enhanced tPA Activity and Therapy

Description:  Researchers at UC have developed methods for inhibiting lysis of coagulated blood and reducing risk of excessive lysis comprising administration of lysis-inhibiting amounts of apolipoprotein E4, and methods for inhibiting lysis of coagulated blood and reducing risk of excessive lysis comprising administration of a specific level of a lysis-inhibiting agent wherein the specific level is based on the apolipoprotein phenotype of an individual, are provided. Methods for enhancing lysis of coagulated blood by administration of an Apo E peptide fragment to blood containing a clot lysis agent are also provided.

2 Issued US patents - 7,208,288 and 7,135,305


For more information please contact Kellen Sensor at 513-558-5621 or Kellen.Sensor@uc.edu



Back to Technologies
 
Printer Friendly Version of Enhanced tPA Activity and Therapy - 100037









Copyright Information © Copyright 2004-2012 university of Cincinnati, Ohio. All rights reserved.